巨春蓉, 门同义, 薛武军, 等. 器官移植受者诺卡菌病诊疗进展[J]. 器官移植. DOI: 10.3969/j.issn.1674-7445.2024124
引用本文: 巨春蓉, 门同义, 薛武军, 等. 器官移植受者诺卡菌病诊疗进展[J]. 器官移植. DOI: 10.3969/j.issn.1674-7445.2024124
Ju Chunrong, Men Tongyi, Xue Wujun, et al. Progress in the diagnosis and treatment of nocardiosis in organ transplant recipients[J]. ORGAN TRANSPLANTATION. DOI: 10.3969/j.issn.1674-7445.2024124
Citation: Ju Chunrong, Men Tongyi, Xue Wujun, et al. Progress in the diagnosis and treatment of nocardiosis in organ transplant recipients[J]. ORGAN TRANSPLANTATION. DOI: 10.3969/j.issn.1674-7445.2024124

器官移植受者诺卡菌病诊疗进展

Progress in the diagnosis and treatment of nocardiosis in organ transplant recipients

  • 摘要: 诺卡菌感染后引起的组织与器官损害统称为诺卡菌病。实体器官移植受者(SOTR)因接受免疫抑制治疗,免疫功能较弱,各种病原体感染的机会明显增加,包括诺卡菌感染。既往诺卡菌病诊断具有一定难度,随着分子生物学等检测手段的出现,其诊断率已显著提高。诺卡菌不仅容易导致肺部坏死性病变,还可能侵犯累及其他器官组织,如颅内感染及皮肤软组织感染,并可发展为全身性播散性感染。对SOTR而言,诺卡菌病是一种潜在致命的疾病,病死率高达30%。因此,本文就SOTR中常见诺卡菌病的临床特点、新型诊断技术及不同的抗感染治疗策略等方面进行综述,以期为临床SOTR诺卡菌病的防治提供参考。

     

    Abstract: Nocardiosis is a collective term for tissue and organ damage caused by Nocardia infection. Solid organ transplant recipients (SOTR) are at an increased risk of various pathogen infections, including Nocardia infection, due to immunosuppressive therapy which weakens their immune function. The diagnosis of nocardiosis has been challenging in the past. With the advent of molecular biology and other diagnostic methods, the diagnostic rate has significantly improved. Nocardia not only prone to cause necrotic pulmonary lesions but also invade other organs and tissues, such as intracranial infections and skin soft tissue infections, and can develop into systemic disseminated infections. For SOTR, nocardiosis is a potentially fatal disease with a fatality as high as 30%. Therefore, this article reviews the clinical characteristics of common nocardiosis in SOTR, new diagnostic technologies, and different anti-infective treatment strategies, aiming to provide a reference for the prevention and treatment of nocardiosis in clinical SOTR.

     

/

返回文章
返回